Communiqués Panacea Life Sciences Holdings, Inc.

Actions

PLSH

US69810P1093

Marché Fermé - OTC Markets Autres places de cotation 21:20:59 02/07/2024			Varia. 5j.	Varia. 1 janv.
0,0891 ^USD	-29,00 %		-42,52 %	-40,60 %

06/05	Panacea Life Sciences Holdings, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
01/04	Panacea Life Sciences Holdings, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	16/05	AQ
Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	16/05	PU
Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	05/10/23	AQ
Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	02/10/23	AQ
Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs	08/08/23	AQ
Panacea Life Sciences Holdings, Inc. Continues Pursuit of High Growth Health and Wellness Products with Acquisition of Sierra Sage, LLC and Halucenex from Melodial Global Health (formerly Creso Pharma Limited)	02/08/23	AQ
Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms	20/07/23	AQ
Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast	18/07/23	NE
Panacea Life Sciences Holdings, Inc. Enters Into Agreement to Natural Health and Wellness Chain of Retail Locations in Tampa, Florida	10/07/23	AQ
Panacea Life Sciences Holdings, Inc. Adopts Diversification Plan: Vegan, Organic, Nutraceuticals, Alternative Health and Wellness Products and Investigative Research Plans for Psylocibin and other Psychedelics.	07/07/23	AQ
Panacea Life Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K.	15/06/23	AQ
PANACEA LIFE SCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	02/06/23	AQ
Panacea Life Sciences Holdings, Inc. Discusses Acquisition Strategy and International Expansion with The Stock Day Podcast	20/04/23	NE
Panacea Life expands CBD business into Guyana, South America to capitalize on the country’s rapid growth	19/04/23	AQ
Panacea Life Sciences Holdings, Inc. Discusses 100% Customer Base Increase and 2023 Goals with The Stock Day Podcast	04/04/23	NE
PANACEA LIFE SCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-K)	30/03/23	AQ
PANACEA’S MANUFACTURING DIVISION INCREASES ITS CUSTOMER BASE BY 100%. IN FIRST QUARTER 2023	27/03/23	AQ
PANACEA LIFE SCIENCES HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	14/02/23	AQ
PANACEA LIFE SCIENCES HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23/01/23	AQ
Panacea Announces Letter of Intent to Acquire N7 Enterprises, Inc.	23/01/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Panacea Life Sciences Holdings, Inc.

Actions

PLSH

US69810P1093

Communiqués

Filtres